 placebo-controlled trial immunotherapy extracts Dermatophagoides pteronyssinus allergic rhinitis clinical outcome changes antigen-specific IgE IgG IgG subclasses double-blind placebo-controlled trial immunotherapy patients Dermatophagoides pteronyssinus rhinitis Thirty patients extract high content Der Pharmalgen conventional mite extract Allpyral patients histamine chloride placebo Specific IgG subclasses months treatment RIA and/or ELISA specific IgE RAST Clinical outcome skin prick tests nasal challenge visual analogue diary-card symptom drug scores findings clinical index IgG response Pharmalgen-treated group pter IgG months months levels treatment IgG/IgE ratio subclass switch pter IgE months Clinical improvement months Pharmalgen-treated group Pretreatment levels IgE clinical outcome findings compatible hypothesis IgG antigen-IgE interactions antibody response potent improvement